Back to Trades
Prudo-Chlebosz Raymond
DirectorCIK 0001653262
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Across 2 filings between 2025–2026, Prudo-Chlebosz Raymond, Director, has disclosed $843.1K in transactions — all concentrated in Akari Therapeutics Plc (AKTX). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Oct 16 | AKTX Akari Therapeutics Plc | Prudo-Chlebosz Raymond | Director | Grant | $97.3K |
| Dec 18 | AKTX Akari Therapeutics Plc | Prudo-Chlebosz Raymond | Director | Other | $390.4K |
2 filings